Garry E Menzel - Net Worth and Insider Trading

Over the past 18 months, Garry E Menzel made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,140,000 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 221,600 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 221,600 shares. During the past 18 months, 246,600 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,075,850 shares were bought by its insiders, resulting in a net purchase of 4,829,250 shares.

Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Garry E Menzel made no insider transaction in TCR2 Therapeutics Inc (TCRR). Other recent insider transactions involving TCR2 Therapeutics Inc (TCRR) include a net sale of 70,170 shares made by Ansbert Gadicke , a net sale of 70,170 shares made by Mpm Asset Management Llc , and a net purchase of 50,000 shares made by Kevin C Tang .

In summary, during the past 3 months, insiders sold 0 shares of TCR2 Therapeutics Inc (TCRR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 140,340 shares of TCR2 Therapeutics Inc (TCRR) were sold and 50,000 shares were bought by its insiders, resulting in a net sale of 90,340 shares.

TCR2 Therapeutics Inc (TCRR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Garry E Menzel made no insider transaction in DaVita Inc (DVA). Other recent insider transactions involving DaVita Inc (DVA) include a net sale of 175,000 shares made by Javier Rodriguez , a net sale of 28,936 shares made by Kathleen Alyce Waters , and a net sale of 71,607 shares made by Michael David Staffieri .

In summary, during the past 3 months, insiders sold 210,888 shares of DaVita Inc (DVA) in total and bought 0 shares, with a net sale of 210,888 shares. During the past 18 months, 375,506 shares of DaVita Inc (DVA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 375,506 shares.

DaVita Inc (DVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Garry E Menzel made no insider transaction in Regulus Therapeutics Inc (RGLS). Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 14,580 shares made by Joseph P Hagan , a net sale of 5,468 shares made by Christopher Ray Aker , and a net sale of 5,468 shares made by Crispina Calsada .

In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 21,516 shares.

Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Garry E Menzel made no insider transaction in Stoke Therapeutics Inc (STOK). Other recent insider transactions involving Stoke Therapeutics Inc (STOK) include a net sale of 134,116 shares made by Barry Ticho , a net sale of 18,022 shares made by Jonathan Allan , and a net sale of 56,616 shares made by Huw M. Nash .

In summary, during the past 3 months, insiders sold 1,967,500 shares of Stoke Therapeutics Inc (STOK) in total and bought 0 shares, with a net sale of 1,967,500 shares. During the past 18 months, 5,803,870 shares of Stoke Therapeutics Inc (STOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,803,870 shares.

Stoke Therapeutics Inc (STOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Garry E Menzel made 1 insider transaction in Adaptimmune Therapeutics PLC (ADAP) with a net sale of 47,702. Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 73,322 shares made by Adrian Rawcliffe , a net sale of 35,120 shares made by John Lunger , and a net sale of 32,818 shares made by Bertrand William C Jr .

In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 245,864 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 245,864 shares.

Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.